Hugo Levillain

6PUBLICATIONS
36CO-AUTHORS
Instruments and techniquesPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 28, 2026
211At targeted alpha therapy in Europe: overcoming clinical, regulatory, and infrastructure challenges.

|Apr 30, 2025
Development and Validation of an 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Zelda Paquier, Jennifer Dhont, Thomas Guiot

|Jan 12, 2021
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres.

Hugo Levillain, Oreste Bagni, Christophe M Deroose

|Dec 14, 2020
Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer.

Hugo Levillain, Manuela Burghelea, Ivan Duran Derijckere

|Jul 21, 2019
Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study.

Hugo Levillain, Ivan Duran Derijckere, Lieveke Ameye

|Jul 15, 2018
90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer.

Hugo Levillain, Ivan Duran Derijckere, Gwennaëlle Marin

Pageof 1

Frequent Collaborators

2 joint publications

Patrick Flamen

1 joint publications

Oreste Bagni

1 joint publications

Christophe M Deroose

1 joint publications

Arnaud Dieudonné